Furthermore, while both the AKT2 gene and miRNA-4716-3p are capable of differentiating between blood cancer patients and healthy individuals on their own, our findings indicated that the two combined exhibited improved diagnostic efficacy (Fig. 4). The gene discussed is AKT2; the disease is cancer.